Further investigation in human HCC cells and in a xenograft mouse model validates the roles of SFXN1 in lipid metabolism and mitochondrial function, and clarifies that loss of SFXN1 expression facilitates tumorigenic property under fat-loading conditions in non-viral HCC. The gene discussed is SFXN1; the disease is hepatocellular carcinoma.